anmelden
FTSE 100
10.325,35
PKT
+60,03
PKT
+0,58
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE 100-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 04.05.17 | HSBC Neutral | UBS AG | |
| 04.05.17 | Imperial Brands buy | UBS AG | |
| 04.05.17 | Shell (ex Royal Dutch Shell) buy | UBS AG | |
| 04.05.17 | Rio Tinto buy | Deutsche Bank AG | |
| 04.05.17 | Imperial Brands buy | Deutsche Bank AG | |
| 04.05.17 | Imperial Brands Neutral | JP Morgan Chase & Co. | |
| 04.05.17 | International Consolidated Airlines Neutral | JP Morgan Chase & Co. | |
| 04.05.17 | National Grid Sector Perform | Robert W. Baird & Co. Incorporated | |
| 04.05.17 | Imperial Brands Conviction Buy | Goldman Sachs Group Inc. | |
| 03.05.17 | BP buy | Deutsche Bank AG | |
| 03.05.17 | Imperial Brands buy | UBS AG | |
| 03.05.17 | BP buy | UBS AG | |
| 03.05.17 | Prudential buy | Deutsche Bank AG | |
| 03.05.17 | Diageo overweight | JP Morgan Chase & Co. | |
| 03.05.17 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 03.05.17 | BP Neutral | Goldman Sachs Group Inc. | |
| 02.05.17 | BP Hold | S&P Capital IQ | |
| 02.05.17 | Lloyds Banking Group Sell | Citigroup Corp. | |
| 02.05.17 | BT Group Neutral | UBS AG | |
| 02.05.17 | National Grid overweight | Morgan Stanley | |
| 02.05.17 | GSK Equal-Weight | Morgan Stanley | |
| 02.05.17 | Lloyds Banking Group buy | HSBC | |
| 02.05.17 | Imperial Brands Conviction Buy List | Goldman Sachs Group Inc. | |
| 02.05.17 | Lloyds Banking Group Sell | Goldman Sachs Group Inc. | |
| 28.04.17 | Barclays buy | S&P Capital IQ | |
| 28.04.17 | Imperial Brands Neutral | Citigroup Corp. | |
| 28.04.17 | Vodafone Group buy | Deutsche Bank AG | |
| 28.04.17 | BT Group Sell | Deutsche Bank AG | |
| 28.04.17 | Lloyds Banking Group overweight | Barclays Capital | |
| 28.04.17 | AstraZeneca buy | Deutsche Bank AG | |
| 28.04.17 | AstraZeneca market-perform | Bernstein Research | |
| 28.04.17 | Barclays Sector Perform | Robert W. Baird & Co. Incorporated | |
| 28.04.17 | AstraZeneca Reduce | HSBC | |
| 27.04.17 | AstraZeneca Sell | S&P Capital IQ | |
| 27.04.17 | Lloyds Banking Group Outperform | Robert W. Baird & Co. Incorporated | |
| 27.04.17 | AstraZeneca buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 27.04.17 | Lloyds Banking Group overweight | Barclays Capital | |
| 27.04.17 | AstraZeneca Neutral | UBS AG | |
| 27.04.17 | GSK buy | Goldman Sachs Group Inc. | |
| 27.04.17 | Standard Chartered buy | Goldman Sachs Group Inc. |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.